Year All20232022202120202019201820172016201520142013 05.16.23 BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition PDF Version 05.12.23 BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights PDF Version 04.26.23 BELLUS Health Announces Meeting Updates PDF Version 04.18.23 GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health PDF Version 04.05.23 BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation PDF Version 03.21.23 BELLUS Health Reports Year 2022 Financial Results and Business Highlights PDF Version 03.01.23 BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference PDF Version 02.08.23 BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting PDF Version
05.16.23 BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition PDF Version
05.12.23 BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights PDF Version
04.18.23 GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health PDF Version
04.05.23 BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation PDF Version
02.08.23 BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting PDF Version
